Method for treating the central nervous system by administration of IGF structural analogs

Details for Australian Patent Application No. 2001288443 (hide)

Owner Aurogen Inc.

Inventors Ishii, Douglas N.

Agent Pizzeys

Pub. Number AU-B-2001288443

PCT Pub. Number WO02/17951

Priority 60228633 29.08.00 US

Filing date 28 August 2001

Wipo publication date 13 March 2002

Acceptance publication date 7 June 2007

International Classifications

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 38/30 (2006.01) Medicinal preparations containing peptides - Insulin-like growth factors (Somatomedins), e.g. IGF-1, IGF-2

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/14 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

27 November 2003 Assignment before Grant

  Colarado State University Research Foundation The application has been assigned to Aurogen Inc. Assignments before Grant, Section 113

7 June 2007 Application Accepted

  Published as AU-B-2001288443

11 October 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001288444

2001288442